We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.26B
AUM Growth
+$740M
Cap. Flow
+$520M
Cap. Flow %
9.89%
Top 10 Hldgs %
40.34%
Holding
110
New
23
Increased
31
Reduced
29
Closed
25

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$178M
2
AGN
Allergan plc
AGN
+$168M
3
GILD icon
Gilead Sciences
GILD
+$89.7M
4
BABA icon
Alibaba
BABA
+$67.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$66.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$93.9M
2
BPMC
Blueprint Medicines
BPMC
+$77.2M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$73.7M
4
PFE icon
Pfizer
PFE
+$50.2M
5
ELV icon
Elevance Health
ELV
+$42.9M

Sector Composition

Rank Sector Weight
1 Healthcare 55.27%
2 Technology 8.75%
3 Communication Services 4%
4 Consumer Discretionary 3.22%
5 Financials 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRTS
101
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-374,656
Closed -$4.98M
SPLK
102
DELISTED
Splunk Inc
SPLK
– –
-90,080
Closed -$11.2M
MRTX
103
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-120,166
Closed -$8.81M
APTX
104
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-1,795,149
Closed -$7.27M
WCG
105
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-314,500
Closed -$84.8M
PVTL
106
DELISTED
Pivotal Software, Inc.
PVTL
– –
-584,051
Closed -$12.2M
ALDR
107
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-2,306,367
Closed -$31.5M
DATA
108
DELISTED
Tableau Software, Inc.
DATA
– –
-121,435
Closed -$15.5M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2019 Portfolio in Review

As of Q2 2019, PFM Health Sciences held 110 positions worth $5.26B, up 16% from $4.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences deployed $520M of net new capital in Q2 2019, opening 23 new positions and adding to 31 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 2,079,388 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 55% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $93.9M trimmed.

  • PFM Health Sciences's largest Q2 2019 buy was BioMarin Pharmaceuticals: 2,079,388 shares worth $178M.
  • PFM Health Sciences added most to Allergan plc in Q2 2019, an estimated $168M increase.
  • PFM Health Sciences's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $93.9M.
  • PFM Health Sciences fully exited Blueprint Medicines in Q2 2019, selling an estimated $77.2M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $5.26B portfolio in Q2 2019.
  • PFM Health Sciences opened 23 new positions and closed 25 in Q2 2019.
  • PFM Health Sciences's portfolio value rose 16% quarter-over-quarter to $5.26B.

Based on PFM Health Sciences's 13F filing for Q2 2019, filed 14 Aug 2019.